The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients

Title
The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients
Authors
Keywords
Melanoma, Adjuvant therapy, Randomised trials, Nivolumab, Ipilimumab, Dabrafenib, Trametinib
Journal
EUROPEAN JOURNAL OF CANCER
Volume 86, Issue -, Pages 101-105
Publisher
Elsevier BV
Online
2017-09-30
DOI
10.1016/j.ejca.2017.09.014

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search